跳至主要内容
临床试验/CTRI/2017/12/011016
CTRI/2017/12/011016已完成3 期

Single dose intranasal fentanyl for the reduction of pain associated with screening for retinopathy of prematurity : a randomized controlled trial

Surya Hospital1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2018年1月28日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
112
试验地点
1
主要终点
1.PIPP score (Premature infant pain profile) during screening for retinopathy of prematurity

研究概览

简要总结

Standard pain relief measures used in neonates such as oral sucrose, oral paracetamol, proparacaine eye drops, EBM, non nutritive sucking , swaddling, KMC etc may be inadequate in relieving pain associated with screening  for ROP.

Intranasal fentanyl is a standard analgesic used in children for severe pain.

We hypothesized that administration of fentanyl intranasally in addition to standard pain relief would result in a further 50 % reduction in Pain score (PIPP)in premature neonates undergoing ROP screening . 56 patients would  need to be recruited for a study power of 90% and two tailed alpha of 0.05.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

年龄范围
30.00 Day(s) 至 34.00 Day(s)(—)
性别
All

入选标准

  • Neonates 30-34 weeks postmenstrual age undergoing screening for retinopathy of prematurity.

排除标准

  • 1.Infant receiving sedation or analgesic medications for any reason.
  • 2.Infants on mechanical ventilation.
  • 3.Any congenital malformations, or neurological dysfunction.
  • 4.Parents refusing consent.

结局指标

主要结局

1.PIPP score (Premature infant pain profile) during screening for retinopathy of prematurity

时间窗: 1.PIPP score (Premature infant pain profile) during screening for retinopathy of prematurity

次要结局

  • 1.PIPP score during screening for retinopathy of prematurity(2.PIPP score post laser :time point 1,5,10 minutes post procedure)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验